<DOC>
	<DOC>NCT02345096</DOC>
	<brief_summary>This study aims to evaluate the effect of a specific strain of Saccharomyces cerevisiae on improving the effectiveness of conventional treatment of vulvo-vaginal candidiasis. This is a randomized, double-blind, placebo-controlled study.</brief_summary>
	<brief_title>Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis, Vulvovaginal</mesh_term>
	<criteria>Premenopausal female patient with a clinical diagnosed vulvovaginal candidiasis Regularly menstruating women with normal gynaecological status Patient must use a contraception method Having given a written informed consent prior to selection Covered by Health Insurance System and / or in compliance with the recommendations of National Law in force relating to biomedical research. Pregnancy or breast feeding. Tumors in the genital tract or beast. Hypersensitivity to the study product. Uterine or vaginal bleeding of unknown origin. Use of systemic or intravaginal antibiotic or antifungal agents in the previous 14 days. Concomitant medication with antimycotics for other diagnoses. Woman with known transmitted infections such as Neisseria gonorrhoea, Chlamydia trachomatis, Treponema pallidum, herpes simplex, Trichomonas vaginalis, human papilloma virus, HIV 1 or 2. Immunocompromised individuals. Subjects not willing to stop taking probiotics in the form of dietary supplements or convenient goods Subject who, in the judgment of the Investigator, is likely to be noncompliant or uncooperative during the study, or unable to cooperate because of a language problem, poor mental development. Subject under administrative or legal supervision. Subject who participate to a previous study within 3 months.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>